Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00730704 · ClinicalTrials.gov registry record
Acceptance of Human Papillomavirus Vaccination in Postpartum Women
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 150
- Enrollment target
NCT00730704 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 150 participants.
The verdict
NCT00730704 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
Worldwide cervical cancer remains a major cause mortality among women. It is estimated that each year over 490,000 women are diagnosed with cervical cancer and more than 270,000 die from the disease. While the implementation of widespread screening programs has reduced the burden of cervical cancer, a large percentage of the population still remains unscreened or is underscreened. It is now recognized that human papillomavirus (HPV) is a necessary precursor for the development of cervical cancer. The first vaccine to prevent HPV was recently approved by the Food and Drug Administration and is now available at doctors offices. Despite the availability of a safe and effective means for the prevention of cervical cancer, widespread implementation of vaccination has been extremely difficult. Several potential issues have limited the development of widespread HPV vaccination programs, including cultural and religious beliefs, and limitations in the practicality of administering the vaccine. The overall goals of our work are to improve access to preventive strategies for cervical cancer. In this proposal we will examine the strategy of HPV vaccination for women who have just given birth. We believe that HPV vaccination of these women will be associated with a high level of patient satisfaction and acceptance. If successful, this strategy could play a major role in advancing the acceptance and implementation of HPV vaccination in the United States.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00730704
The ClinicalTrials.gov registry entry for NCT00730704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00730704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00730704 about?
NCT00730704 is a clinical study titled "Acceptance of Human Papillomavirus Vaccination in Postpartum Women". Worldwide cervical cancer remains a major cause mortality among women. It is estimated that each year over 490,000 women are diagnosed with cervical cancer and more than 270,000 die from the disease. While the implementation of widespread screening programs has reduced the burden of cervical cancer,...
What is the current status of trial NCT00730704?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2009-05. Estimated completion is 2012-10.
Who is sponsoring clinical trial NCT00730704?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.